… In this context, the HFA has prepared this position document to (i) describe the clinical
characteristics of patients with advanced heart failure, (ii) inform physicians about markers of poor …

… heart failure. Patients may move between stages/classes in either direction but the natural
history of heart failure is … Stage A = “at high risk of HF but without structural heart disease or …

… failure, although attempts have been made to develop a staging system.2 For right heart
failure … herein propose a staging system of RVD and right heart failure (Table 2). However, the …

Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the
monitoring of heart transplant (HTx) rejection. In addition, EMB can have an important …

… Heart failure is a serious condition and equivalent to malignant disease in terms of symptom
… number of heart failure patients receive specialist palliative care. Heart failure patients may …

… in individuals with stable chronic heart failure (CHF). … The overall prevalence of heart failure
in general Australian population … The two main causes of heart failure are hypertension and …

… The vast majority of acute heart failure episodes are … position paper focuses on the use of
diuretics in heart failure … /resistance in the treatment of acute heart failure, (iii) an approach …

… heart failure therapies, premature discontinuation of decongestive therapies, or ongoing
renal injury.8-10 This position paper … of kidney function throughout the heart failure trajectory. …

The coexistence of type 2 diabetes mellitus (T2DM) and heart failure (HF), either with
reduced (HFrEF) or preserved ejection fraction (HFpEF), is frequent (30–40% of patients) and …

… Heart Failure Association of the European Society of Cardiology Working Group on PPCM
2010 PPCM is an idiopathic cardiomyopathy presenting with heart failure … of heart failure is …